Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: January 2012
Santorum's baby puts spotlight on genetic disorder
Posted: Published on January 30th, 2012
In this June 6, 2011 file photo, former Pennsylvania Sen. Rick Santorum holds his daughter Bella before announcing he is entering the Republican presidential race, on the steps of the Somerset County Courthouse in Somerset, Pa. Bella has the genetic disorder Trisomy 18, and was hospitalized over the weekend with pneumonia. (Credit: AP) (CBS) Bella Santorum, the 3-year-old daughter of Republican presidential candidate Rick Santorum, was hospitalized over the weekend with pneumonia and complications from the genetic disorder, Trisomy 18. Also known as Edwards syndrome, Trisomy 18 occurs when a person is born with three copies of the 18th chromosome, as opposed to two. That extra chromosome interferes with typical childhood development, causing children to be born with clenched hands, crossed legs, feet with rounded bottoms, a small head and jaw, and intellectual disabilities. The disorder can also cause serious heart and kidney problems. Trisomy 18 occurs in about one out of every 3,000 births. It is three times more common in girls than boys, according to the National Institutes of Health. Unlike Down syndrome, which is caused by an extra chromosome 21, the issues caused by Trisomy 18 are associated with more life-threatening medical complications and 50 percent of … Continue reading
Comments Off on Santorum's baby puts spotlight on genetic disorder
Stanford scientists turn skin cells into neural precusors, bypassing stem-cell stage
Posted: Published on January 30th, 2012
Public release date: 30-Jan-2012 [ | E-mail | Share ] Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center STANFORD, Calif. ? Mouse skin cells can be converted directly into cells that become the three main parts of the nervous system, according to researchers at the Stanford University School of Medicine. The finding is an extension of a previous study by the same group showing that mouse and human skin cells can be directly converted into functional neurons. The multiple successes of the direct conversion method could refute the idea that pluripotency (a term that describes the ability of stem cells to become nearly any cell in the body) is necessary for a cell to transform from one cell type to another. Together, the results raise the possibility that embryonic stem cell research and another technique called "induced pluripotency" could be supplanted by a more direct way of generating specific types of cells for therapy or research. This new study, which will be published online Jan. 30 in the Proceedings of the National Academy of Sciences, is a substantial advance over the previous paper in that it transforms the skin cells into neural precursor cells, as opposed to neurons. While … Continue reading
Comments Off on Stanford scientists turn skin cells into neural precusors, bypassing stem-cell stage
Stanford scientists turn skin cells into neural precusors, bypassing stem-cell stage
Posted: Published on January 30th, 2012
Public release date: 30-Jan-2012 [ | E-mail | Share ] Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center STANFORD, Calif. ? Mouse skin cells can be converted directly into cells that become the three main parts of the nervous system, according to researchers at the Stanford University School of Medicine. The finding is an extension of a previous study by the same group showing that mouse and human skin cells can be directly converted into functional neurons. The multiple successes of the direct conversion method could refute the idea that pluripotency (a term that describes the ability of stem cells to become nearly any cell in the body) is necessary for a cell to transform from one cell type to another. Together, the results raise the possibility that embryonic stem cell research and another technique called "induced pluripotency" could be supplanted by a more direct way of generating specific types of cells for therapy or research. This new study, which will be published online Jan. 30 in the Proceedings of the National Academy of Sciences, is a substantial advance over the previous paper in that it transforms the skin cells into neural precursor cells, as opposed to neurons. While … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on Stanford scientists turn skin cells into neural precusors, bypassing stem-cell stage
ACT Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived …
Posted: Published on January 30th, 2012
MARLBOROUGH, Mass.--(BUSINESSWIRE)-- Second Site for First Human Embryonic Stem Cell Trial in Europe Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Aberdeen Royal Infirmary, the largest of the Grampian University Hospitals in Scotland, has been confirmed as a site for its Phase 1/2 human clinical trial for Stargardt’s Macular Dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The Phase 1/2 trial is a prospective, open-label study designed to determine the safety and tolerability of the RPE cells following sub-retinal transplantation into patients with SMD. “A leading medical institution in the United Kingdom, Aberdeen Royal Infirmary is an ideal partner for our European clinical trial for SMD,” said Gary Rabin, chairman and CEO of ACT. “Moreover, we are particularly pleased that the lead investigator is Dr. Noemi Lois, a leading expert in SMD. We continue to forge ties with some of the best eye surgeons and hospitals in the world and work towards bringing this cutting-edge therapy closer to fruition. Our preliminary results to date keep us optimistic that we are on the right path both in terms of our science and the clinical team … Continue reading
Posted in Stem Cell Human Trials
Comments Off on ACT Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived …
Stem-Cell-Financing – Video
Posted: Published on January 30th, 2012
24-01-2012 19:07 http://www.StemCellTreatment.org Need stem cell financing? We are the only stem cell treatment clinic that offers financing to qualified individuals. Stem cell financing is offered most treatment types but not all. If your interested in stem cell finance then please visit our website and fill out the form on home page and one of the credit officers will get back to you. Read more: Stem-Cell-Financing - Video … Continue reading
Comments Off on Stem-Cell-Financing – Video
RBCC Explores New Cures for Cancer, Brain Injuries & Headaches
Posted: Published on January 30th, 2012
NOKOMIS, Fla.--(BUSINESS WIRE)-- Cutting-edge stem cell research is producing new breakthroughs that could potentially revolutionize the treatment of currently incurable diseases from cancer to brain injuries to headaches. Rainbow Coral Corp. (OTCBB:RBCC.OB - News), an emerging biotechnology company, is hard at work identifying and targeting promising new stem-cell treatments for commercialization. As the world’s population ages and the economic might of emerging countries such as China and India blossoms, the market is increasing daily for new and effective cures to old ailments. RBCC plans to capitalize on recent growth in the biosciences sector by commercializing advanced-stage research with the potential to produce new treatments. RBCC is aiming high. The company’s current target, n3D Biosciences, has developed a breakthrough cell-culturing system that allows scientists to grow 3D stem cells that behave much more similarly to cells found in the body. This product may directly assist with advanced discoveries to find cures for common injuries and diseases. With the help of its new allies in BioHouston, RBCC plans to identify new targets on the cutting-edge of biotechnology for acquisition and joint venture. Through its biotech division, Rainbow BioSciences, RBCC is working to develop new medical and research technology innovations to compete alongside … Continue reading
Posted in Stem Cell Research
Comments Off on RBCC Explores New Cures for Cancer, Brain Injuries & Headaches
What are stem cells? How can they be used for medical benefit? – Video
Posted: Published on January 30th, 2012
12-12-2009 13:45 What are stem cells? - An short educational film by the Irish Stem Cell Foundation Stem cells are master cells of the body — want to learn more? Visit http://www.irishstemcellfoundation.org ISCF is an independent not-for-profit organisation whose primary objective is to educate about stem cells, their basic biology and the research and therapies using them. The Foundation will initially focus on education outreach programs, hoping to address the growing problem of bogus stem cell scams being offered to Irish patients over the internet. The Foundation will also assist the development of Irish policy and legislature in this area of medicine and science, ensuring Ireland is informed. The Foundation consists of a broad range of people including Irish doctors, scientists, patient advocates, educators, bioethicists and other associated parties seeking to expand and develop the Irish public's understanding of stem cells. Read the rest here: What are stem cells? How can they be used for medical benefit? - Video … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on What are stem cells? How can they be used for medical benefit? – Video
Lecture by stem cell researcher tomorrow
Posted: Published on January 30th, 2012
Celebrated adult stem cell researcher Shinya Yamanaka will deliver a lecture, ‘New era of medicine with iPS cells', here on Monday as part of a three-city lecture series. Prof. Yamanaka's scientific breakthrough was the creation of embryonic-like stem cells from adult skin cells. The lecture by this Japanese physician is the third edition of The Cell Press-TNQ India Distinguished Lectureship Series. He will also deliver it in Chennai on February 1 and New Delhi on February 3. The lecture series is co-sponsored by Cell Press and TNQ Books and Journals. Quantum leap The stated goal of Prof. Yamanaka's laboratory has been to generate pluripotent stem cells from human somatic cells. The ability to re-programme adult cells back into an earlier, undifferentiated state has helped to reshape the ethical debate over stem cell research by providing an approach to obtain pluripotent stem cells that need not be harvested from an embryo. Prof. Yamanaka, who was awarded the Albert Lasker Prize in 2009 and the Wolf Prize in 2011, is the director of the Centre for iPS Cell Research and Application and professor at the Institute for Frontier Medical Sciences at Kyoto University. He is also a senior investigator at the UCSF-affiliated … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on Lecture by stem cell researcher tomorrow
BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Posted: Published on January 30th, 2012
JUPITER, Fla., Jan. 23, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX.PK - News) ("BRT") today announced that it will be presenting at the Seventh International Conference on Cell Therapy for Cardiovascular Disease. The event, being held at the New York-Presbyterian Hospital/Columbia University Medical Center, is a two-and-a-half-day conference dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease. Dr. Amit Patel, Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and a member of the BRT Scientific Advisory Board, will be presenting his findings relating to brown fat stem cells and metabolic disorders (one of BRT's stem cell initiatives). His talk, entitled "Metabolic Syndrome: A Role For Cell Therapy," will be on Wednesday, January 25th at 1:50 PM. Mark Weinreb, Chairman and CEO of BRT, has also been selected to serve on an industry panel and will discuss BRT's ThermoStem™ Program and the use of brown fat stem cells as potential therapeutics. The session will be held on Thursday, January 26th from 3:15-4:15 PM. BRT is involved in a research initiative focusing on the use of Brown Fat stem cells to potentially treat metabolic disorders and obesity that … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Training the Next Generation of Stem Cell Scientists: CIRM Bridges Program – Video
Posted: Published on January 30th, 2012
13-10-2011 11:02 The CIRM Bridges to Stem Cell Research Awards are training the next generation of stem cell scientists and laboratory technicians by funding courses and research internships for undergraduates and masters-level students. At the 2011 CIRM Bridges Trainee Meeting, 160 students from the 16 Bridges programs presented posters that describe the research results from their internships and learned about career opportunities in stem cell science. Series: "California Institute for Regenerative Medicine" [10/2011] [Science] [Show ID: 22636] See original here: Training the Next Generation of Stem Cell Scientists: CIRM Bridges Program - Video … Continue reading
Posted in Stem Cell Research
Comments Off on Training the Next Generation of Stem Cell Scientists: CIRM Bridges Program – Video